Subscribe To Our Free Newsletter |
Alembic Pharmaceuticals Limited – Press Release
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 29-Aug-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Chlorthalidone Tablets USP, 25 mg and 50 mg......